---
title: "Amyloid-β in Parkinson's disease and Alzheimer's disease"
collection: Markers
order: 6
permalink: /brain/amyloidbeta
---
Amyloid-β (Aβ) plays a significant role in both Alzheimer's disease (AD) and Parkinson's disease (PD), though its involvement differs between these neurodegenerative disorders.

### **In Alzheimer's Disease (AD):**
Amyloid-β is a central component of Alzheimer's disease pathology. The accumulation of Aβ peptides forms extracellular plaques in the brain, which are one of the hallmark features of AD. These plaques are believed to trigger a cascade of pathological events leading to neuronal death, including:

- **Synaptic dysfunction:** Aβ disrupts synaptic communication between neurons, impairing cognitive function.
- **Inflammation:** The presence of Aβ activates microglia, the brain's immune cells, leading to chronic neuroinflammation.
- **Oxidative stress:** Aβ promotes the generation of reactive oxygen species (ROS), causing oxidative damage to neurons.
- **Tau pathology:** Aβ aggregation is thought to precede and potentially promote the formation of neurofibrillary tangles composed of hyperphosphorylated tau protein, another key feature of AD.

The "amyloid cascade hypothesis" suggests that Aβ accumulation is the initiating event in AD, leading to a progressive neurodegenerative process.

### **In Parkinson's Disease (PD):**
While the role of Aβ is less central in PD compared to AD, emerging research indicates that Aβ may contribute to the pathophysiology of PD in several ways:

- **Lewy body formation:** Some studies suggest that Aβ can interact with alpha-synuclein, the protein that forms Lewy bodies (a hallmark of PD). This interaction may promote alpha-synuclein aggregation, exacerbating neurodegeneration in PD.
- **Cognitive decline:** Aβ plaques have been found in the brains of patients with Parkinson's disease, particularly in those with Parkinson’s disease dementia (PDD). The presence of Aβ in these patients is associated with more severe cognitive impairment.
- **Mitochondrial dysfunction and oxidative stress:** Similar to AD, Aβ can induce oxidative stress and mitochondrial dysfunction, both of which are implicated in PD pathogenesis.

### **Shared Mechanisms:**
- **Neuroinflammation:** In both diseases, Aβ contributes to chronic neuroinflammation, which may aggravate neuronal loss and cognitive dysfunction.
- **Mitochondrial dysfunction:** Aβ promotes mitochondrial dysfunction and oxidative damage, common pathological mechanisms in both AD and PD.
- **Protein aggregation:** The co-aggregation of Aβ with alpha-synuclein in some cases suggests a shared pathway for protein misfolding and aggregation between the diseases.

Though Aβ is more prominent in AD, its potential role in PD highlights the overlapping pathological mechanisms between these two neurodegenerative disorders. Understanding these shared pathways could provide insights into therapeutic strategies for both conditions.

---

